ResMed Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RMD research report →
About the company
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service.
- CEO
- Michael J. Farrell
- IPO
- 1995
- Employees
- 9,980
- HQ
- San Diego, CA, US
Price Chart
- Market Cap
- $30.41B
- P/E
- 20.20
- P/S
- 5.49
- P/B
- 4.73
- EV/EBITDA
- 13.54
- Div Yield
- 1.14%
- Gross Margin
- 61.69%
- Op Margin
- 34.28%
- Net Margin
- 27.44%
- ROE
- 24.41%
- ROIC
- 19.63%
- Revenue
- $5.15B · 9.84%
- Net Income
- $1.40B · 37.20%
- EPS
- $9.55 · 37.61%
- Op Income
- $1.69B
- FCF YoY
- 29.18%
- 52W High
- $293.81
- 52W Low
- $180.27
- 50D MA
- $201.71
- 200D MA
- $239.14
- Beta
- 0.78
- Avg Volume
- 1.43M
Get TickerSpark's AI analysis on RMD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 8, 26 | Farrell Michael J. | other | 4,991 |
| Jun 8, 26 | Farrell Michael J. | sell | 4,991 |
| Jun 8, 26 | Farrell Michael J. | other | 4,991 |
| May 7, 26 | Farrell Michael J. | other | 4,991 |
| May 7, 26 | Farrell Michael J. | sell | 4,991 |
| May 7, 26 | Farrell Michael J. | other | 4,991 |
| May 4, 26 | Bloomer Aaron | other | 0 |
| May 4, 26 | Sandercock Brett | other | 0 |
| Apr 7, 26 | Farrell Michael J. | other | 4,991 |
| Apr 7, 26 | Farrell Michael J. | sell | 4,991 |
Our RMD coverage
Recent articles, reports, and earnings notes.
Want a deeper read on RMD?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.